FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma

Zeyu Zhang(Chongqing Medical University), Changzhu Duan(Chongqing Medical University), Yarui Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingxi Du(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaobing Wang(University of Science and Technology of China), Xiaolei Guo(Yangzhou Polytechnic Institute), Qing Zhu(Xi'an Jiaotong University)
Frontiers in Pharmacology
October 8, 2021
Cited by 209


Related Papers